Torbjørn Omland group

Group strategy

The group's main strategy is to conduct high-quality, translational and clinical- epidemiological research in the field of cardiovascular medicine. To achieve this goal the group has established an extensive collaborative network with leading investigators, nationally and internationally.

Specific strategic goals include:
To discover novel cardiovascular biomarkers in experimental models of myocardial ischemia and heart failure
To assess diagnostic and prognostic value of cardiovascular biomarkers in large cohorts of patients with heart failure and acute coronary syndromes, as well as in population-based studies
To investigate the impact of cardiovascular disease mechanisms in other illness, including chronic obstructive pulmonary disease, obstructive sleep apnea, and mental depression

Head of group

Omland, Torbjørn


Torbjørn Omland

Professor, MD, PhD

Helge Røsjø


Helge Røsjø


Group members

Webmaster Vidar, IEMF